The global Non-Therapeutic Antibiotics for Food Animals Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Oxytetracyclines, Tylosin, Ampicillin and Amoxycillin, Gentamicin, Sulfaquinoxaline, Salinomycin, Bacitracin, Others), By Application (Cattle Feed, Poultry Feed, Swine Feed, Aqua Feed, Others)
The Non-Therapeutic Antibiotics for Food Animals Market involves the production and sale of antibiotics used in livestock and poultry farming to promote growth and prevent diseases, rather than treating illnesses. The market is driven by increasing demand for high-quality animal protein, rising awareness about the benefits of antibiotics for animal health, and growing applications in animal husbandry. Additionally, advancements in antibiotic production technologies and the expansion of product applications support market growth.
The market report analyses the leading companies in the industry including AG Sanofi, AG Zoetis Inc, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals, Eli Lilly and Company, Merck & Co. Inc, Vetoquinol S.A., Virbac, and Others.
The most prominent trend in the Non-Therapeutic Antibiotics for Food Animals Market is the increasing scrutiny and regulatory restrictions. Governments and regulatory bodies worldwide are implementing stricter regulations to curb the use of non-therapeutic antibiotics in livestock due to concerns over antibiotic resistance and food safety. This trend is driven by the need to protect public health and ensure the sustainability of food animal production systems.
A key driver in the Non-Therapeutic Antibiotics for Food Animals Market is the growing awareness of antibiotic resistance. As the public and healthcare professionals become more aware of the dangers posed by antibiotic-resistant bacteria, there is increasing pressure on the agricultural industry to reduce the use of antibiotics in livestock. This demand supports the market as stakeholders seek alternatives to maintain animal health and productivity.
One significant opportunity in the Non-Therapeutic Antibiotics for Food Animals Market lies in the development of alternative health solutions. Companies can innovate by creating natural and sustainable products such as probiotics, prebiotics, and herbal supplements that support animal health without the use of antibiotics. By offering effective and safe alternatives, manufacturers can meet regulatory requirements and consumer demands, driving market growth.
In the Non-Therapeutic Antibiotics for Food Animals Market, Oxytetracyclines is the largest segment. This prominence is attributed to their broad-spectrum antimicrobial activity and long history of use in veterinary medicine. Oxytetracyclines are commonly used to enhance growth rates and feed efficiency in livestock, making them a staple in non-therapeutic applications. Their effectiveness against a wide range of bacterial pathogens, coupled with their established regulatory approvals and cost-effectiveness, solidifies their leading position in the market. Additionally, oxytetracyclines' application across various food animals, including cattle, poultry, and swine, further supports their dominance in the non-therapeutic antibiotics segment.
In the Non-Therapeutic Antibiotics for Food Animals Market, the Aqua Feed application segment is poised to grow the fastest over the next five years. This growth is driven by the expanding aquaculture industry and the increasing demand for seafood globally. Non-therapeutic antibiotics are used in aqua feed to promote growth, improve feed conversion rates, and prevent diseases in fish and other aquatic species. The rise in fish farming, driven by the need to meet rising seafood consumption and address overfishing concerns, is fueling the demand for effective and efficient feed additives, including non-therapeutic antibiotics. As the aquaculture industry continues to expand, the aqua feed segment is expected to experience significant growth.
By Type
Oxytetracyclines
Tylosin
Ampicillin and Amoxycillin
Gentamicin
Sulfaquinoxaline
Salinomycin
Bacitracin
Others
By Application
Cattle Feed
Poultry Feed
Swine Feed
Aqua Feed
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
AG Sanofi
AG Zoetis Inc
Bayer AG
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals
Eli Lilly and Company
Merck & Co. Inc
Vetoquinol S.A.
Virbac
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Non Therapeutic Antibiotics for Food Animals Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Non Therapeutic Antibiotics for Food Animals Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Non Therapeutic Antibiotics for Food Animals Market Share by Company, 2023
4.1.2. Product Offerings of Leading Non Therapeutic Antibiotics for Food Animals Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Non Therapeutic Antibiotics for Food Animals Market Drivers
6.2. Non Therapeutic Antibiotics for Food Animals Market Challenges
6.6. Non Therapeutic Antibiotics for Food Animals Market Opportunities
6.4. Non Therapeutic Antibiotics for Food Animals Market Trends
Chapter 7. Global Non Therapeutic Antibiotics for Food Animals Market Outlook Trends
7.1. Global Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
Oxytetracyclines
Tylosin
Ampicillin and Amoxycillin
Gentamicin
Sulfaquinoxaline
Salinomycin
Bacitracin
Others
By Application
Cattle Feed
Poultry Feed
Swine Feed
Aqua Feed
Others
Chapter 8. Global Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.1. Global Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.2.2. Canada Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.2.3. Mexico Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.3. Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.3.2. France Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.3.3. United Kingdom Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.3.4. Spain Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.3.5. Italy Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.3.6. Russia Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.3.7. Rest of Europe Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.4. Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Country (2021-2032)
8.4.1. China Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.4.2. Japan Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.4.3. India Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.4.4. South Korea Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.4.5. Australia Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.4.6. South East Asia Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.5. South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.5.2. Argentina Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.5.3. Rest of South America Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.6. Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
8.6.2. Africa Non Therapeutic Antibiotics for Food Animals Regional Analysis and Outlook
Chapter 9. North America Non Therapeutic Antibiotics for Food Animals Analysis and Outlook
9.1. North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Product (2021-2032)
By Type
Oxytetracyclines
Tylosin
Ampicillin and Amoxycillin
Gentamicin
Sulfaquinoxaline
Salinomycin
Bacitracin
Others
By Application
Cattle Feed
Poultry Feed
Swine Feed
Aqua Feed
Others
Chapter 10. Europe Non Therapeutic Antibiotics for Food Animals Analysis and Outlook
10.1. Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Product (2021-2032)
By Type
Oxytetracyclines
Tylosin
Ampicillin and Amoxycillin
Gentamicin
Sulfaquinoxaline
Salinomycin
Bacitracin
Others
By Application
Cattle Feed
Poultry Feed
Swine Feed
Aqua Feed
Others
Chapter 11. Asia Pacific Non Therapeutic Antibiotics for Food Animals Analysis and Outlook
11.1. Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Product (2021-2032)
By Type
Oxytetracyclines
Tylosin
Ampicillin and Amoxycillin
Gentamicin
Sulfaquinoxaline
Salinomycin
Bacitracin
Others
By Application
Cattle Feed
Poultry Feed
Swine Feed
Aqua Feed
Others
Chapter 12. South America Non Therapeutic Antibiotics for Food Animals Analysis and Outlook
12.1. South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Product (2021-2032)
By Type
Oxytetracyclines
Tylosin
Ampicillin and Amoxycillin
Gentamicin
Sulfaquinoxaline
Salinomycin
Bacitracin
Others
By Application
Cattle Feed
Poultry Feed
Swine Feed
Aqua Feed
Others
Chapter 13. Middle East and Africa Non Therapeutic Antibiotics for Food Animals Analysis and Outlook
13.1. Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) by Product (2021-2032)
By Type
Oxytetracyclines
Tylosin
Ampicillin and Amoxycillin
Gentamicin
Sulfaquinoxaline
Salinomycin
Bacitracin
Others
By Application
Cattle Feed
Poultry Feed
Swine Feed
Aqua Feed
Others
Chapter 14. Non Therapeutic Antibiotics for Food Animals Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
AG Sanofi
AG Zoetis Inc
Bayer AG
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals
Eli Lilly and Company
Merck & Co. Inc
Vetoquinol S.A.
Virbac
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Non Therapeutic Antibiotics for Food Animals Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Non Therapeutic Antibiotics for Food Animals Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Non Therapeutic Antibiotics for Food Animals Market Share (%) By Regions (2021-2032)
Table 12 North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Table 15 South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Region (2021-2032)
Table 17 North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Type (2021-2032)
Table 18 North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Application (2021-2032)
Table 19 North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Product (2021-2032)
Table 26 South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Type (2021-2032)
Table 27 South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Application (2021-2032)
Table 28 South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Non Therapeutic Antibiotics for Food Animals Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Non Therapeutic Antibiotics for Food Animals Market Share (%) By Regions (2023)
Figure 6. North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 12. France Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 12. China Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 14. India Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Non Therapeutic Antibiotics for Food Animals Revenue (USD Million) By Product (2021-2032)
By Type
Oxytetracyclines
Tylosin
Ampicillin and Amoxycillin
Gentamicin
Sulfaquinoxaline
Salinomycin
Bacitracin
Others
By Application
Cattle Feed
Poultry Feed
Swine Feed
Aqua Feed
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Non-Therapeutic Antibiotics for Food Animals Market Size is valued at $XX Million in 2024 and is forecast to register a growth rate (CAGR) of 7.7% to reach $XX Million by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
AG Sanofi, AG Zoetis Inc, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals, Eli Lilly and Company, Merck & Co. Inc, Vetoquinol S.A., Virbac
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume